Risk Factors and Drug Therapy Monitoring in CKD Patients (Chronic Kidney Disease)
Chronic Kidney Disease (CKD) is a global health problem that affects millions of people, characterized by a progressive decline in kidney function. This study aims to determine Drug Related Problems (DRPs) in the treatment management of CKD (Chronic Kidney Disease) patients. This study used the literature review method. The research results from the collected literature will be summarized and presented in the form of descriptive analysis. Researchers will conduct literature searches through online sites such as Google Scholar, PubMed, ResearchGate, Elsevier, and NCBI. The keywords used are “CKD risk factors” and “drug therapy for CKD patients”. The results of the search for relevant literature will be collected and selected according to the inclusion criteria. The research results from the collected literature will be presented in the form of a descriptive table. The table will include information such as author, year of publication, article title, and summary of the study results. The prevalence of drug-related problems (DRP) in CKD patients ranges from 12% to 87%. Commonly found problems include ineffective treatment, inappropriate drug selection, and drug dosing issues. Regular drug monitoring and dose adjustment are essential to reduce adverse drug reactions and improve patient outcomes. Effective drug therapy management and patient education are essential to improve the quality of care and life of CKD patients. In conclusion, this study emphasizes the importance of identifying and addressing drug-related problems (DRPs) to improve treatment effectiveness in CKD patients. Close drug monitoring and comprehensive patient education are key components in the optimal management of CKD.
Adiana, Sylvi, and Devi Maulina. 2022. “Klasifikasi Permasalahan Terkait Obat (Drug Related Problem/DRPs).” Indonesian Journal of Health Science 2(2): 54–58.
Al-Worafi, Yaser Mohammed. 2020. “Drug-Related Problems.” In Drug Safety in Developing Countries, Elsevier, 105–17.
Aprianti, Sartika, Prayudi Santoso, Melisa Intan Barliana, and Ivan Surya Pradipta. 2023. “Article Review: The Treatment Problem And Adverse Drug Reactions In The Treatment Of Multidrug-Resistant Tuberculosis.” Medical Sains: Jurnal Ilmiah Kefarmasian 8(4): 1503–24.
Currivan, Mark. 2021. The Drug Recognition Guide. John Wiley & Sons.
Febriyantara, Arif, Okti Sri Purwanti, and M Kep. 2016. “Hubungan Antara Kepatuhan Menjalani Terapi Hemodialisa Dan Kualitas Hidup Pasien Chronic Kidney Disease (CKD) Di Rumah Sakit Dr. Moewardi.”
Hasballah, Kartini. 2022. Farmakologi Geriatri. Syiah Kuala University Press.
Kardela, Widya, Rezlie Bellatasie, Nurayni Nurayni, and Erlina Rustam. 2022. “Evaluasi Masalah Terkait Obat Pada Pasien Diabetes Melitus Tipe II Dengan Gagal Ginjal Kronik Di Rawatan Inap RSUP DR. M. Djamil Padang.” Jurnal Farmasi Higea 14(1): 72–78.
Munir, Badrul, Meddy Setiawan, Febri Endra Budi Setyawan, and Feny Tunjungsari. 2022. “Tatalaksana Komprehensif Gangguan Ginjal Pada Pekerja Industri Gula.” CoMPHI Journal: Community Medicine and Public Health of Indonesia Journal 3(2): 94–109.
Naidoo, S, and A M Meyers. 2015. “Drugs and the Kidney.” South African medical journal 105(4): 332–37.
Rahman, Shahrul. 2020. “Tatalaksana Hemodialisis Pada Anak Dan Bayi.” Cermin Dunia Kedokteran 47(4): 291–96.
Rosdewi, Rosdewi, Yuliana Tola’ba, Mardiana Syahrul, and Desryany Tika. 2023. “Pengaruh Hemodialisis Terhadap Nilai Hemoglobin Pada Pasien End Stage Renal Disease Di Rs. Stella Maris Makassar.” Jurnal Ners 7(1): 68–73.
Suhadi, Rita et al. 2020. Seluk Beluk Hipertensi: Peningkatan Kompetensi Klinis Untuk Pelayanan Kefarmasian. Sanata Dharma University Press.
Vadakedath, Sabitha, and Venkataramana Kandi. 2017. “Dialysis: A Review of the Mechanisms Underlying Complications in the Management of Chronic Renal Failure.” Cureus 9(8).
Wanadiatri, Halia. 2019. “Metabolisme Obat Pada Penyakit Kardiovaskuler.” Jurnal Kedokteran 4(2): 1–4.
Yang, Wei et al. 2014. “Association of Kidney Disease Outcomes with Risk Factors for CKD: Findings from the Chronic Renal Insufficiency Cohort (CRIC) Study.” American journal of kidney diseases 63(2): 236–43.
Copyright (c) 2024 Rosliana Patandung, Riski Ishariyanto, Debi Mariska Sune
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-ShareAlike 4.0 International (CC-BY-SA). that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
